Early Access Programmes Europe
October 12 - 14, 2015 - London UKPharma IQ
enquire@iqpc.co.uk
Phone:+44 (0) 207 036 1300
The pharmaceutical and biotechnology pipeline has become much more specialty focused, with more and more drugs treating rare diseases now going through into main development. In order to meet the demand for these investigational drugs and ensure an equitable supply, sponsor companies are tasked with accurately anticipating demand and strategically planning to ensure they can successfully implement and execute these early access programmes.
This website uses cookies to ensure you get the best experience on our website. Learn more